Vertex Pharmaceuticals· @VertexPharma · X·· 2026-06-01精选AI 评分62
AI 导读
Vertex 宣布美国 FDA 已受理其针对 IgA 肾病（IgAN）在研疗法的生物制品许可申请（BLA）。该疗法目前仍处于在研阶段，公司未在帖文中披露具体药品名称或审评时间表。
推荐理由
原文披露FDA受理其IgA肾病在研疗法的BLA，读者可据此跟踪该适应症后续审评进展。
正文
We are proud to announce that the U.S. FDA has accepted our Biologics License Application (BLA) for our investigational therapy for #IgANephropathy. Learn more: https://news.vrtx.com/news-releases/news-release-details/vertex-announces-us-fda-acceptance-biologics-license-application
来源：Vertex Pharmaceuticals · x.com